Search Results
Sep 30, 2025, 10:40 ET ZOOMLION dévoile le DX7004, le tracteur à roues hybride le plus puissant du monde
Zoomlion Heavy Industry Science & Technology Co, Ltd. (1157.HK) a officiellement lancé le tracteur à roues hybride le plus puissant du monde, le DX7004, dans sa Smart Industry City à Changsha. Annoncé par le président-directeur général Zhan Chunxin, cet engin de près de quatre mètres de haut est doté
More news about: Zoomlion
Sep 30, 2025, 10:35 ET ZOOMLION presenta el tractor de ruedas híbrido más potente del mundo, el DX7004
-- Zoomlion Heavy Industry Science & Technology Co., Ltd. (1157.HK) lanzó oficialmente el tractor de ruedas híbrido más potente del mundo, el DX7004, en su Smart Industry City en Changsha. Anunciado por el presidente y consejero delegado, Zhan Chunxin, esta máquina de casi cuatro metros de altura
More news about: Zoomlion
Sep 30, 2025, 10:29 ET ZOOMLION stellt den weltweit leistungsstärksten Hybrid-Radtraktor DX7004 vor
& Technology Co., Ltd. (1157.HK) hat in seiner Smart Industry City in Changsha offiziell den weltweit leistungsstärksten Hybrid-Radtraktor, den DX7004, vorgestellt. Die vom Vorsitzenden und Geschäftsführer Zhan Chunxin angekündigte, fast vier Meter hohe Maschine verfügt über eine hochmoderne Hybridantriebstechnologie
More news about: Zoomlion
Sep 30, 2025, 09:30 ET Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
SALT LAKE CITY, Sept. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be
More news about: Co-Diagnostics
Sep 29, 2025, 13:48 ET Vantage Market Research: Global Companion Diagnostics Market Size & Share to Surpass USD 31.75 Billion by 2035, Growing at a CAGR 11.75% | Powering Precision Medicine, Targeted Therapies and Next-Gen Drug Development
Expansion: Non-invasive, blood-based tests enabling real-time monitoring of treatment response. Pharma–Dx Alliances: Co-developed assays speeding clinical trial recruitment and regulatory approvals. Beyond
More news about: Vantage Market Research
Sep 29, 2025, 03:01 ET 줌라이언, 세계에서 가장 힘센 하이브리드 바퀴형 트랙터 DX7004 공개
Industry Science & Technology Co., Ltd.)(홍콩 증권거래소 상장 코드: 1157)가 자사의 지능형 산업 복합 단지인 스마트 인더스트리 시티(Smart Industry City)에서 세계에서 가장 힘 좋은 하이브리드 바퀴형 트랙터 DX7004를 정식으로 출시했다. 회장 겸 CEO 잔 춘신(Zhan Chunxin)이 발표한 바에 따르면, 높이가 4미터에 육박하는 이 트랙터는 최첨단 하이브리드 구동 기술을 탑재하여 전 세계 고성능 농업 장비의 새로운 기준을 제시한다.
More news about: Zoomlion
Sep 28, 2025, 17:07 ET ズームライオン、世界最高出力のハイブリッドホイールトラクター「DX7004」を正式発表
中国長沙、2025年9月29日/PRNewswire/― ズームライオン(Zoomlion)重工業科学技術有限公司（1157.HK）は、長沙のスマート産業都市において、世界最高出力のハイブリッドホイールトラクター「DX7004」を正式に発表しました。約4メートルもの高さを持つこの機械は、会長兼CEOの詹純新氏によって発表され、最先端のハイブリッド駆動技術を備え、世界における高出力農業機械の新たな基準を確立するものです。
More news about: Zoomlion
Sep 28, 2025, 14:10 ET ZOOMLION Unveils the World's Most Powerful Hybrid Wheeled Tractor DX7004
-- Zoomlion Heavy Industry Science & Technology Co., Ltd. (1157.HK) officially launched the world's most powerful hybrid wheeled tractor, the DX7004, at its Smart Industry City in Changsha. Announced by Chairman and CEO Zhan Chunxin, the nearly four-meter-high machine features cutting-edge hybrid
More news about: Zoomlion
Sep 28, 2025, 10:28 ET ZOOMLION Unveils the World's Most Powerful Hybrid Wheeled Tractor DX7004
-- Zoomlion Heavy Industry Science & Technology Co., Ltd. (1157.HK) officially launched the world's most powerful hybrid wheeled tractor, the DX7004, at its Smart Industry City in Changsha. Announced by Chairman and CEO Zhan Chunxin, the nearly four-meter-high machine features cutting-edge hybrid
More news about: Zoomlion
Sep 26, 2025, 09:00 ET COREE宣佈發現糖尿病與肥胖患者獨特微生物組生物標誌物
https://www.prnewswire.com/apac/zh/news-releases/coree-302568210.html SOURCE Dx&Vx
More news about: Dx&Vx
Sep 26, 2025, 09:00 ET COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients
with Italian research teams. The company is led by Chairman Chong-Yoon Lim, who is also the largest shareholder of Dx&Vx. The announcement was made at the 38th Annual Workshop of the European Helicobacter & Microbiota Study Group (EHMSG), held in Rome,
More news about: Dx&Vx
Sep 24, 2025, 04:00 ET UTM Pilot Deployment at Expo 2025 Osaka to Ensure Safe Integration with Advanced Air Mobility
NEC Corporation Smart City Business Development Department, Infrastructure DX Business Division Email: [email protected]
More news about: Intent Exchange, Inc.
Sep 18, 2025, 17:05 ET Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Sept. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of
More news about: Co-Diagnostics
Sep 18, 2025, 08:36 ET Advanced Lateral Flow Conference 2025 Releases Full Agenda
Managing Director, Head of Dx, PM & LST & Services, Health Advances); Brian Weinstein (Managing Director, Medical Technology, William Blair); and Pat Vaughan, Ph.D. (COO, DCN Dx); hosted by Mitzi
More news about: DCN Dx
Sep 17, 2025, 17:31 ET Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period (2025-2034) Due to Breakthrough Therapies in Atopic Dermatitis, Asthma, CRSwNP, and Others | DelveInsight
currently in Phase II trials for moderate-to-severe atopic dermatitis. In mid-2024, ASLAN reported encouraging interim data from the ongoing Phase II TREK-DX study, which is assessing the therapy in patients who had previously received dupilumab. Results showed that 60% of participants treated with 400 mg
More news about: DelveInsight Business Research, LLP
Sep 17, 2025, 09:47 ET Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Sept. 17, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered
More news about: Co-Diagnostics
Sep 16, 2025, 09:30 ET Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
partner as we explore ways to expand our reach across this important region, for both our upcoming Co-Dx PCR platform as well as our existing suite of lab-based PCR diagnostic products." *The Co-Dx PCR platform (including the PCR Home™, PCR Pro™, mobile app, and all associated tests) is subject
More news about: Co-Diagnostics
Sep 13, 2025, 03:35 ET Lateral Flow Assay Components Market worth US$486.2 million by 2030 with 4.4% CAGR | MarketsandMarkets™
Prahas Healthcare (India), NanoHybrids (US), ProGnosis Biotech S.A. (Greece), Lateral Dx (UK), Bangs Laboratories (US), BBI Solutions (Canada), Sona Nanotech (Canada), and
More news about: MarketsandMarkets